Influenza A virus infection in zebrafish recapitulates mammalian infection and sensitivity to anti-influenza drug treatment

Autor: Kristin A. Gabor, Walter K. Mowel, Carol H. Kim, Michelle F. Goody, P. Eckhard Witten, Remi L. Gratacap, Meghan E. Breitbach
Jazyk: angličtina
Rok vydání: 2014
Předmět:
Medicine (miscellaneous)
lcsh:Medicine
medicine.disease_cause
Virus Replication
Immunology and Microbiology (miscellaneous)
Pandemic
Influenza A virus
Zebrafish
NECROSIS VIRUS
GENE-EXPRESSION
Innate immunity
0303 health sciences
DANIO-RERIO
biology
POLYSIALIC ACID
030302 biochemistry & molecular biology
Influenza research
HUMAN-DISEASE
3. Good health
Virus
Viral load
medicine.drug
Research Article
lcsh:RB1-214
Neuroscience (miscellaneous)
Antiviral Agents
General Biochemistry
Genetics and Molecular Biology

FREE CLICK CHEMISTRY
03 medical and health sciences
Zanamivir
Influenza
Human

medicine
lcsh:Pathology
Animals
Humans
030304 developmental biology
lcsh:R
Biology and Life Sciences
biology.organism_classification
Virology
NERVOUS-SYSTEM
Influenza
MODEL
Disease Models
Animal

TRANSGENIC ZEBRAFISH
Infectious disease (medical specialty)
Immunology
RESPONSES
Zdroj: Disease Models & Mechanisms, Vol 7, Iss 11, Pp 1227-1237 (2014)
Disease Models & Mechanisms
DISEASE MODELS & MECHANISMS
ISSN: 1754-8411
1754-8403
Popis: Seasonal influenza virus infections cause annual epidemics and sporadic pandemics. These present a global health concern, resulting in substantial morbidity, mortality and economic burdens. Prevention and treatment of influenza illness is difficult due to the high mutation rate of the virus, the emergence of new virus strains and increasing antiviral resistance. Animal models of influenza infection are crucial to our gaining a better understanding of the pathogenesis of and host response to influenza infection, and for screening antiviral compounds. However, the current animal models used for influenza research are not amenable to visualization of host-pathogen interactions or high-throughput drug screening. The zebrafish is widely recognized as a valuable model system for infectious disease research and therapeutic drug testing. Here, we describe a zebrafish model for human influenza A virus (IAV) infection and show that zebrafish embryos are susceptible to challenge with both influenza A strains APR8 and X-31 (Aichi). Influenza-infected zebrafish show an increase in viral burden and mortality over time. The expression of innate antiviral genes, the gross pathology and the histopathology in infected zebrafish recapitulate clinical symptoms of influenza infections in humans. This is the first time that zebrafish embryos have been infected with a fluorescent IAV in order to visualize infection in a live vertebrate host, revealing a pattern of vascular endothelial infection. Treatment of infected zebrafish with a known anti-influenza compound, Zanamivir, reduced mortality and the expression of a fluorescent viral gene product, demonstrating the validity of this model to screen for potential antiviral drugs. The zebrafish model system has provided invaluable insights into host-pathogen interactions for a range of infectious diseases. Here, we demonstrate a novel use of this species for IAV research. This model has great potential to advance our understanding of influenza infection and the associated host innate immune response.
Databáze: OpenAIRE